Brazil's INTO (national trauma and orthopaedics institute) receives international quality assurance accreditation:
This article was originally published in Clinica
Executive Summary
Brazil's national trauma and orthopaedics institute (INTO) is being formally awarded a healthcare quality accreditation from Joint Commission International (JCI). The four-year project, headed by the director of INTO's medical division, Isabela Simoes, entailed 367 quality standards across 11 service areas. Five of these are organisational, and include safety and quality of care, access to intensive care and infection control procedures. Five hospital institutions in Brazil and around 70 worldwide have received an international healthcare quality accreditation, according to INTO. JCI is the office of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) that performs accreditations outside the US.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.